Ponatinib User Reviews & Ratings
Brand names: Iclusig
Ponatinib has an average rating of 3.0 out of 10 from a total of 2 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 50% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Acute Lymphoblastic Leukemia | 1 reviews for Acute Lymphoblastic Leukemia | 29 medications | |
Chronic Myelogenous Leukemia | 1 reviews for Chronic Myelogenous Leukemia | 17 medications |
- Mar...
- August 27, 2015
For Acute Lymphoblastic Leukemia "I really hope this was going to work. My side effects were bad, first a rash (very bad). Many creams and strong prescriptions were given with little to no help, but the worst was the heart damage. I had a mild heart attack. The doctor felt strongly it was due to this medication, this is only my experience. I do not want to discourage anybody that it can help, just be careful of all the signs."
See also:
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Bosulif
Bosulif is a kinase inhibitor that may be used to treat adults and some children aged 1 year and ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Are you taking this medicine?
Your review helps others make informed decisions.More about ponatinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
For Chronic Myelogenous Leukemia "I have used Gleevec, Sprycel, and both the above mentioned with Hydrea added. Gleevec made me nauseous, but it worked for a while, for about 1.5 years. I then was switched to Sprycel, which didn't make me nauseated and lasted 3/4 of the year. Now I'm taking Ponatinib, which sometimes upset my stomach, but it was controlling the CML and the T315I mutation. I did develop thrombocythemia, in which thrombocythemia is being difficult to control. But the CML was being kept at bay. This lasted for less than a year. I liked the Ponatinib, little side effects, and it was controlling the CML and the mutation, but it caused the high platelet count. All medicines were great, and I do recommend them in hopes to control the CML."